Clinical Trial Update: Effect of Naloxegol on Gastric, Small Bowel, and Colonic Transit in Healthy Subjects [Phase 1]

View source ↗

Summary

A Phase 1 study in healthy subjects evaluated the effects of naloxegol on gastric, small bowel, and colonic transit to characterize its impact on gastrointestin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid-induced Constipation

Drugs mentioned

• MOVANTIK (Naloxegol oxalate)

Snippet

Sponsor: Michael Camilleri | Conditions: Constipation Drug Induced | Phase 1 | Status: COMPLETED